Acadia Pharmaceuticals Inc. 

CA

  SEC # 1070494

        

Click to view...

Registrant

About

Filings

Files

Relationships

Names

Topics

Web

Registrant
 SEC-Registered:  9/16/98   —   First EDGAR Filing:  12/21/00   –   Last Filing:  4/26/24 

Business Address      On:  4/26/24       [ Map ]		Mailing Address      On:  4/26/24       [ Map ]
12830 El Camino Real Suite 400 San Diego, California  92130 U.S.A.

Phone #		Organized In		Fiscal-Year End		IRS #		SEC CIK		SEC File #
+1 858-558-2871		Delaware, U.S.A.		12/31/yy		06-1376651		0001070494		000-50768

Market: Symbol:  Nasdaq: ACAD

— Common Stock

In Major Indexes:	S&P Total Market — NASDAQ Composite — Russell 2000  &  Russell 3000

Industry Classification
GICS – Global Industry Classification Standard:        Sector      →    Sub-Industry   Health Care Biotechnology   ICB – Industry Classification Benchmark:               Industry    →       Subsector      Health Care Biotechnology   SIC:     Code      U.S. Industry      Through      Source      Filings-Review Office 2834 Pharmaceutical Preparations 2024 SEC Office of Life Sciences

        

Management
Director   In   CA   Davis Stephen 2015-2024   CA   Brege Laura 2008-2023   NY   667, L.P. 2013-2023   NY   Baker Bros. Advisors (GP) LLC 2013-2023   NY   Baker Bros. Advisors LP 2013-2023   NY   Baker Brothers Life Sciences LP 2013-2023   NY   Baker Felix 2013-2023   NY   Baker Julian 2013-2023   CA   Harrigan Edmund 2015-2023   CA   Soland Daniel B 2015-2023   DE   Daly James M 2016-2023   CA   Garofalo Elizabeth A. 2020-2023   Ndu Adora 2022-2023 ↓List Pre-2020 Directors				Officer  Since  Most-Recent Title   In   CA   Rhodes Jennifer J EVP, Chief Legal Officer, Sec 2024   CA   Thompson Elizabeth H.Z. EVP, Head of Research & Dev 2024   CA   Schneyer Mark C. 2021 EVP, Chief Financial Officer 2024   CA   Teehan Brendan 2021 EVP, COO, Head Of Commercial 2024   CA   Kihara James 2020 Principal Accounting Officer 2024   CA   Kim Austin D. 2018 EVP, General Counsel, Secretary 2024   CA   Davis Stephen 2014 CEO 2024   Williamson Douglas J Executive VP, Research & Dev 2023   CA   Stankovic Srdjan R. 2015 President 2022   CA   Ridloff Elena 2019 EVP & CFO 2021   CA   Yang Michael J. 2017 EVP & CCO 2021 ↓List Pre-2020 Officers

        

        

        

        

Securities
Market:  Symbol    Description        (Prices) (Type — Name)   Nasdaq:  ACAD   Common Stock — COM USD.001 _________  Symbol source:  SEC  As of:  4/25/24		CUSIP, CINS or PPN       Description ← Symbol   Issuer Issue (Class or re: Filing — Name)      To 2024:   004225 004225·10·8     Common — COM USD.001 ← ACAD 004225·01·7     Options _________  Classes source:  Form 13F Filings that list Section 13(f) Securities